The rating affirmation is based on several factors, including Holy Name’s solid market position, consistent operating performance and strong revenue growth.
The medical center also faces numerous challenges, including its location in the highly competitive New Jersey market.
The outlook is stable, reflecting Moody’s expectation that Holy Name will maintain stable liquidity and continue to show consistent operating performance.
More articles on healthcare finance:
In pay-for-performance, are hospitals unfairly penalized for patient hardships?
Financial pains of patient accounting systems felt most in the first three months: 7 findings
Medicare Advantage sign-ups surge, defy expectations: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
